Offsets |
May 26, 2026
USD ($)
|
|---|---|
| Offset: 1 | |
| Offset Payment: | |
| Offset Claimed | true |
| Rule 457(p) Offset | true |
| Registrant or Filer Name | NervGen Pharma Corp. |
| Form or Filing Type | F-10 |
| File Number | 333-292197 |
| Initial Filing Date | Dec. 17, 2025 |
| Fee Offset Claimed | $ 12,429.00 |
| Security Type Associated with Fee Offset Claimed | Unallocated (Universal) Shelf |
| Unsold Aggregate Offering Amount Associated with Fee Offset Claimed | $ 90,000,000.00 |
| Termination / Withdrawal Statement | An aggregate registration fee of U.S.$20,715 was previously paid in connection with $150,000,000 of securities registered under the Registration Statement on Form F-10 (File No. 333-292197) (the "Prior Registration Statement") initially filed on December 17, 2025 by the Registrant, including U.S.$12,429.00 paid in relation to $90,000,000 of securities remaining unsold in the offering contemplated by the Prior Registration Statement, which unsold securities are hereby deregistered. Consequently, pursuant to Rule 457(p) of the U.S. Securities Act of 1933, as amended, U.S.$12,429.00 is being offset against the total registration fee due for this Registration Statement. Accordingly, U.S.$22,096 is being paid at the time of filing of this Registration Statement. The Registrants has terminated or completed any offerings that included unsold securities under the Prior Registration Statement. |
| Offset: 2 | |
| Offset Payment: | |
| Offset Claimed | false |
| Rule 457(p) Offset | true |
| Registrant or Filer Name | NervGen Pharma Corp |
| Form or Filing Type | F-10 |
| File Number | 333-292197 |
| Filing Date | Dec. 17, 2025 |
| Fee Paid with Fee Offset Source | $ 20,715.00 |